Oslo University Hospital HF
Oslo University Hospital HF
Oslo, Norway2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI) | Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, liposarcoma, neoplasm, sarcoma | Recruiting | Phase 2 | 2026-08-27 | NCT06389799 | |
| The Lumbar Adjacent Segment Stenosis Trial | bone disorder, musculoskeletal system disorder, spinal stenosis, vertebral column disorder | Not yet recruiting | Not applicable | 2026-06-26 | NCT07670533 |